Published in Thromb Haemost on June 24, 1985
Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol (1994) 1.35
Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci U S A (1998) 1.28
Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden. Proc Natl Acad Sci U S A (1990) 0.91
Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med (1988) 3.15
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr (1989) 2.98
Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94
A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature (1987) 2.48
Prenatal diagnosis and management of bleeding disorders with fetal blood sampling. Am J Obstet Gynecol (1988) 2.45
Prenatal diagnosis of congenital toxoplasmosis. Lancet (1985) 2.43
Prenatal diagnosis of congenital rubella. Lancet (1984) 2.31
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18
Fetal platelet counts in thrombocytopenic pregnancy. Lancet (1990) 2.13
Antenatal thrombocytopenia in three patients with TAR (thrombocytopenia with absent radii) syndrome. Prenat Diagn (1993) 2.11
Magnetic resonance imaging in antenatal diagnosis of tuberous sclerosis. Lancet (1992) 2.09
Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost (1994) 1.96
Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol (1985) 1.94
A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature (1986) 1.90
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1995) 1.76
Failure of fetal karyotyping and diagnosis of complete Di George syndrome. Lancet (1991) 1.68
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol (1996) 1.64
Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol (1991) 1.62
Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res (1991) 1.61
Epidemiology of infective endophthalmitis in France. The French Collaborative Study Group on Endophthalmitis. Lancet (1991) 1.53
Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol (1991) 1.42
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. J Lab Clin Med (1996) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Changes in alpha 1-acid glycoprotein serum concentrations and glycoforms in the developing human fetus. Clin Chim Acta (1991) 1.38
Reply to Weiner (1989;161:1091-2). Am J Obstet Gynecol (1990) 1.38
Prenatal diagnosis of HIV infection: two attempts using fetal blood sampling. J Acquir Immune Defic Syndr (1989) 1.37
Rotavirus infection reduces sucrase-isomaltase expression in human intestinal epithelial cells by perturbing protein targeting and organization of microvillar cytoskeleton. J Virol (1998) 1.33
Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (1997) 1.28
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28
Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn (1992) 1.22
Human amniotic IgA inhibits natural IgG autoantibodies of maternal or unrelated origin. Eur J Immunol (1998) 1.22
Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody. J Exp Med (1986) 1.21
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med (1999) 1.19
Prenatal and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay. J Infect Dis (1988) 1.12
P-glycoprotein expression of the human placenta during pregnancy. Placenta (2005) 1.09
Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases. Prenat Diagn (1983) 1.09
Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis (1988) 1.05
Rapid prenatal diagnosis of Down's syndrome with in-situ hybridisation of fluorescent DNA probes. Lancet (1986) 1.02
Diagnosis of Toxoplasma infection in the pregnant woman and the unborn child: current problems. Scand J Infect Dis Suppl (1992) 1.01
High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol (1998) 1.01
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood (2001) 1.00
Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy. Transfus Med (1992) 0.99
Infection of cultured human intestinal cells by monkey RRV and human Wa rotavirus as a function of intestinal epithelial cell differentiation. Res Virol (1996) 0.99
Perinatal-lethal Gaucher disease. Am J Med Genet A (2003) 0.98
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1998) 0.98
Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res (1986) 0.98
Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost (1997) 0.97
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1999) 0.95
Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG (2007) 0.95
Toxoplasmosis in pregnancy. Lancet (1994) 0.95
Prenatal treatment of alloimmune thrombocytopenia. Lancet (1984) 0.94
[Infectious fetal diseases. Prevention, prenatal diagnosis, practical measures]. Presse Med (1991) 0.94
Developmental hematopoiesis in normal human fetal blood. Blood (1991) 0.94
Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol (1997) 0.93
In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn Ther (1993) 0.93
Influence of intestinal bacterial flora on cytokine (IL-1, IL-6 and TNF-alpha) production by mouse peritoneal macrophages. Eur Cytokine Netw (1993) 0.92
The assessment of fetal blood samples. Am J Obstet Gynecol (1988) 0.92
A new method for the estimation of protein C by ELISA. Thromb Res (1984) 0.92
Pefloxacin concentrations in human aqueous humour and lens. J Antimicrob Chemother (1986) 0.92
Placental transfer of vitamin K1 and its implications in fetal hemostasis. Thromb Haemost (1988) 0.91
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol (1996) 0.91
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Blood (1998) 0.91
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum (1994) 0.91
Lupus Anticoagulant-Hypoprothrombinemia syndrome (HLAS): report of one case in a familial infectious context. Thromb Res (2009) 0.90
Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med (1998) 0.90
A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding. J Biol Chem (1988) 0.89
Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost (1998) 0.89
Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Lancet (1990) 0.89
The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG (2008) 0.89
Separation of red blood cells by field flow fractionation. Exp Hematol (1993) 0.89
Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa (1998) 0.89